(Q37950778)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037104%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

From whole blood to component therapy: the economic, supply/demand need for implementation of component therapy in sub-Saharan Africa (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037104%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037104%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

T C Adias

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037104%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

1 reference

28 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037104%20AND%20SRC:MED&resulttype=core&format=json

Transfusion Clinique et Biologique

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037104%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037104%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

5-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037104%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

516-526

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037104%20AND%20SRC:MED&resulttype=core&format=json

Standardization of the red cell product.

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Pathogen reduction of blood components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Survey of the use of whole blood in current blood transfusion practice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Fresh whole blood transfusion: a controversial military practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

The use of fresh whole blood in massive transfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Fresh whole blood transfusions in coalition military, foreign national, and enemy combatant patients during Operation Iraqi Freedom at a U.S. combat support hospital.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Prevalence and outcomes of anemia in cancer: a systematic review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Clinical practice guideline: red blood cell transfusion in adult trauma and critical care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Allogeneic blood transfusion and prognosis following total hip replacement: a population-based follow up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Effect of early plasma transfusion on mortality in patients with ruptured abdominal aortic aneurysm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Transfusion therapy in postpartum hemorrhage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Massive obstetric haemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Red cell freezing and its impact on the supply chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Long-term storage of peripheral blood stem cells frozen and stored with a conventional liquid nitrogen technique compared with cells frozen and stored in a mechanical freezer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Residual WBC subsets in filtered prestorage RBCs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

PrP expression in B lymphocytes is not required for prion neuroinvasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

The effect of universal leukodepletion of packed red blood cells on postoperative infections in high-risk patients undergoing abdominal aortic surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Risk factors for postoperative infections in patients with hip fracture treated by means of Thompson arthroplasty.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Both infiltrating regulatory T cells and insufficient antigen presentation are involved in long-term cardiac xenograft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Transfusion immunomodulation or TRIM: what does it mean clinically?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Impact of plasma transfusion in massively transfused trauma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

A survey of physicians' reasons to transfuse plasma and platelets in the critically ill: a prospective single-centre cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Correction of coagulopathy in warfarin associated cerebral hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Management of excessive anticoagulant effect due to vitamin K antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Warfarin reversal in anticoagulant-associated intracerebral hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Treatment of congenital fibrinogen deficiency: overview and recent findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

The safety of plasma-derived von Willebrand/factor VIII concentrates in the management of inherited von Willebrand disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

A prospective audit program to determine blood component transfusion appropriateness at a large university hospital: a 5-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Evidence-based platelet transfusion guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Platelet transfusion therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Optimizing platelet transfusion therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Relationship between platelet count and bleeding risk in thrombocytopenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Guidelines for the use of platelet transfusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Meta-analysis of randomized controlled trials of the efficacy of white cell reduction in preventing HLA-alloimmunization and refractoriness to random-donor platelet transfusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

The evaluation and management of platelet refractoriness and alloimmunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Appropriate hospital management of adult immune thrombocytopenic purpura patients in major Italian institutions in 2000-2002: a retrospective analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Clinical use of Haemate P in inherited von Willebrand's disease: a cohort study on 100 Italian patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Haemophilia B: Christmas disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

An open clinical study assessing the efficacy and safety of Factor IX Grifols, a high-purity Factor IX concentrate, in patients with severe haemophilia B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Continuous intravenous infusion of a plasma-derived factor IX concentrate (Mononine) in haemophilia B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Guidelines on the management of massive blood loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Recommendations for the Management of Intracranial Haemorrhage – Part I: Spontaneous Intracerebral Haemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Surgical interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Fluid therapy and the use of albumin in the treatment of severe traumatic brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Volume expansion with albumin compared to gelofusine in children with severe malaria: results of a controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

When is an albumin infusion needed?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Antenatal administration of Rh-immune globulin causes significant increases in the immunomodulatory cytokines transforming growth factor-β and prostaglandin E2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Subcutaneous anti-D globulin application is a safe treatment option of immune thrombocytopenia in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Intravenous human plasma-derived augmentation therapy in alpha 1-antitrypsin deficiency: from pharmacokinetic analysis to individualizing therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001

Aralast: an alpha 1-protease inhibitor for the treatment of alpha-antitrypsin deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.06.001